<?xml version="1.0" encoding="UTF-8"?>
<ref id="B88-ijms-21-09049">
 <label>88.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Raisova</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Hossini</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Eberle</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Riebeling</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Orfanos</surname>
    <given-names>C.E.</given-names>
   </name>
   <name>
    <surname>Geilen</surname>
    <given-names>C.C.</given-names>
   </name>
   <name>
    <surname>Wieder</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Sturm</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Daniel</surname>
    <given-names>P.T.</given-names>
   </name>
  </person-group>
  <article-title>The Bax/Bcl-2 Ratio Determines the Susceptibility of Human Melanoma Cells to CD95/Fas-Mediated Apoptosis</article-title>
  <source>J. Investig. Dermatol.</source>
  <year>2001</year>
  <volume>117</volume>
  <fpage>333</fpage>
  <lpage>340</lpage>
  <pub-id pub-id-type="doi">10.1046/j.0022-202x.2001.01409.x</pub-id>
  <pub-id pub-id-type="pmid">11511312</pub-id>
 </element-citation>
</ref>
